Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H15N3O5S |
InChIKeyJXZXJHWSQKISBZ-UHFFFAOYSA-N |
CAS Registry315239-63-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 13 Feb 2014 |